Identifying adolescents with high fasting glucose: the importance of adding grandparents' data when assessing family history of diabetes by Brandão, M et al.
Preventive Medicine 57 (2013) 500–504
Contents lists available at ScienceDirect
Preventive Medicine
j ourna l homepage: www.e lsev ie r .com/ locate /ypmedIdentifying adolescents with high fasting glucose: The importance of adding
grandparents' data when assessing family history of diabetes
Mariana Brandão a, Carla Lopes a,b, Elisabete Ramos a,b,⁎
a Department of Clinical Epidemiology, Predictive Medicine and Public Health, University of Porto Medical School, Alameda Professor Hernâni Monteiro, 4200 - 319 Porto Portugal
b Institute of Public Health, University of Porto (ISPUP), Rua das Taipas, nº 135, 4050-600, Porto Portugal⁎ Corresponding author at: Department of Clinical Epid
and Public Health, University of Porto Medical Schoo
Monteiro, 4200 - 319 Porto Portugal. Fax: +351 225 513
E-mail addresses: marbran@gmail.com (M. Brandão
eliramos@med.up.pt (E. Ramos).
0091-7435/$ – see front matter © 2013 Elsevier Inc. All
http://dx.doi.org/10.1016/j.ypmed.2013.06.028a b s t r a c ta r t i c l e i n f oAvailable online 9 July 2013Keywords:
Type 2 diabetes mellitus
Adolescent
Abnormal glycemia
Family history
Objective. To evaluate the role of adding grandparents' data to parental information to the assessment of a
family history of diabetes, in order to identify adolescents with high fasting glucose.
Method. In 2003 we evaluated 1276 population-based 13-year-olds, from Porto, Portugal. The history of
diabetes in parents and grandparents was collected using self-reported questionnaires and a clinical eval-
uation was performed, including a fasting blood sample. The 75th percentile of fasting plasma glucose
(FPG = 91 mg/dl) was used to create two groups of participants (high vs. low fasting glucose).Results. No association was found between family history of diabetes (with or without grandparental
data) and a high FPG. The sensitivity to identify individuals with high FPG increased from 7.8% to 47.9%
when grandparental history was combined with parental data. The positive predictive value was slightly
increased (25.2% vs. 27.8%) but the speciﬁcity dropped (91.8% vs. 56.4%).
Conclusion. Combining parental with grandparental history increased the number of adolescents with a
positive family history of diabetes and also increased the sensitivity to identify adolescents with high FPG.
So, even if it determines a decrease in speciﬁcity, grandparental data is relevant when screening for high
fasting glucose in adolescents.© 2013 Elsevier Inc. All rights reserved.Introduction
The prevalence of Type 2 diabetes mellitus (T2DM) among children
and adolescents is increasing worldwide, mostly due to the epidemic of
overweight and obesity in these age groups (Alberti et al., 2004).
Since more young individuals develop T2DM, their propensity to
develop diabetes' related complications is bigger. Hence, identifying
adolescents at higher risk of developing the disease must be a priority.
Namely, because those complications result from a continuous expo-
sure to high plasma glucose values and can occur even in those individ-
uals with impaired fasting glucose (IFG) or impaired glucose tolerance
(Reinehr et al., 2006; WHO, 2006).
In order to minimize these potential consequences, the Consensus
Panel of the American Diabetes Association (ADA) recommends screen-
ing for T2DM at the age of 10 or at the onset of puberty (when puberty
occurs at a younger age), if there is a high probability of developing di-
abetes. Besides being overweight or obese, one of the screening criteria
to identify adolescents is a family history of T2DM in a ﬁrst- or second-
degree relatives (ADA, 2012). Wei et al. (Wei et al., 2010) conducted
a large study that supports this recommendation, suggesting that aemiology, Predictive Medicine
l, Alameda Professor Hernâni
653.
), carlal@med.up.pt (C. Lopes),
rights reserved.parental or grandparental history of diabetes is associated with an in-
creased risk of T2DM in children. However, ADA recommendations re-
garding screening are not widely followed in clinical practice (Drobac
et al., 2004; Rhodes et al., 2006; van Esch et al., 2013).
Using family history information as a screening tool is appealing in
both clinical and community settings, because it is easy and inexpensive
to collect. Unfortunately, among younger adolescents there is a huge
probability of misclassiﬁcation regarding family history based only on
parental data, since most of their parents are still in their 40s and 50s
and a large proportion of subjects younger than 50 years of age are
still undiagnosed (DECODE, 2003). Thus, data about grandparents' his-
tory of diabetes may help to minimize this misclassiﬁcation.
Despite the low prevalence of T2DM at early adolescence, having
high fasting plasma glucose (FPG) level, even within the normoglycemic
range, is a predictor of type 2 diabetes in younger adulthood (Nguyen
et al., 2010). Therefore, the goal of our study is to evaluate the role of
adding grandparental data to parental information to the assessment of
a family history of diabetes, in order to identify adolescents with high
fasting plasma glucose.
Methods
Participants
The studywas developed as part of the Epidemiological Health Investigation
of Teenagers in Porto (EPITeen). Eligible participants were adolescents born in
501M. Brandão et al. / Preventive Medicine 57 (2013) 500–5041990 and enrolled at public and private schools in Porto during the 2003/2004
school year (Ramos and Barros, 2007). We identiﬁed 2787 eligible adolescents,
and 2160 (1561 public and 509 private school students) agreed to participate.
This resulted in a 77.5% overall participation, with a similar level in both public
(77.7%) and private schools (77.0%, p = 0.709).Ethics
The Ethical Committee of the University Hospital of São João, Porto, ap-
proved the study. Written informed consent was obtained from both parents
and adolescents.Data collection
The evaluation included two self-administered questionnaires and a physical
examination. The home questionnaire, answered by adolescents and parents, in-
quired into demographic, social, behavioral and clinical history. Parents reported
their usual weight and height (this information being used to calculate body
mass index – BMI) and their smoking status. Based on parents' education, adoles-
cents were classiﬁed, taking into account the parent with a higher level of educa-
tion, and this information was used as a proxy for socioeconomic status.
Information about a medical diagnosis of diabetes was asked separately
to the mother, father and each of the grandparents. We have classiﬁed Parental
History (PH) as: a) positive, when at least one of the adolescent's parents had a
diagnosis of diabetes; b) negative, when both parents reported absence of dia-
betes or c) non classiﬁable, when the available information showed no diagno-
sis of diabetes, but, at least, one of the parents reported to “be unaware” or did
not answer. Total Family History (TFH) was computed taking into account the
information on parental and grandparental diagnosis of diabetes.We have clas-
siﬁed TFH as: a) positive,when at least one of the adolescent's relatives (parents
or grandparents) had a diagnosis of diabetes; b) negative, when all relatives re-
ported absence of diabetes; c) non classiﬁable, when the available information
about relatives showed no diagnosis of diabetes, but there was missing or “un-
aware” information about, at least, one relative.
A physical examination was performed at school by a team of health pro-
fessionals. Anthropometrics were obtained with the subject in light indoor
clothes and no shoes. Weight was measured using a digital scale Tanita®
(in kilograms, to the nearest 0.1 kg) and height was measured (in centimeters,
to the nearest tenth) using a portable stadiometer. BMI was classiﬁed according
to the age-speciﬁc percentiles developed by the United States Centers for
Disease Control and Prevention (Kuczmarski et al., 2002) as overweight (BMI
between the 85th - 95th percentile) and obese (BMI ≥95th percentile).
A 12-h overnight fasting blood sample was drawn from consenting par-
ticipants. Plasma glucose was measured using automatic standard routine en-
zymatic methods. Insulin was measured by radioimmunoassay (Coat-A-CountR,
Diagnostic Products Corporation, Los Angeles, California, USA). Insulin resistance
was assessed by the Homeostatic Model Assessment (HOMA-IR) method, based
on fasting glucose and insulin concentrations (Matthews et al., 1985) Insulin
sensitivity was determined by the Quantitative Insulin Sensitivity Check Index
method (QUICKI)(Katz et al., 2000).
We classiﬁed adolescents according to their FPG levels, and adolescents
equal or above the 75th percentile of FPG (which is 91 mg/dl) were classiﬁed
as "high FPG".Table 1
Comparison of FPG, FPI, HOMA-IR and QUICKI according to the categories: Low Fasting
Glucose (FPG b 75th percentile) and High Fasting Glucose (FPG ≥ 75th percentile).
Total
(n = 1276)
Mean (SE)
Low fasting glucose
(n = 944)
Mean (SE)
High fasting glucose
(n = 332)
Mean (SE)
p-valuea
FPI (μIU/ml)b 8.22 (5.53) 7.73 (5.16) 9.60 (6.27) b0.001
HOMA-IR b 1.75 (1.23) 1.56 (1.05) 2.28 (1.53) b0.001
QUICKI b 0.38 (0.09) 0.39 (0.09) 0.36 (0.08) b0.001
a p-value refers to the comparison between the group with FPG b 75th percentile and
those with FPG ≥ 75th percentile. FPG 75th percentile = 91 mg/dl. b FPG: Fasting
Plasma Glucose. FPI: Fasting Plasma Insulin; HOMA-IR: HOMA-insulin resistance;
QUICKI: quantitative insulin sensitivity check index.Statistical analyses
Proportions were compared using the Chi-square test or Fisher's exact
test. Means were presented as mean (standard error) and compared using
the T-Student or One-Way ANOVA; additionally, to compare values according
to the 3 categories of family history, the Bonferroni method was used for
post-hoc comparisons. Odds Ratio and 95% Conﬁdence Intervals were esti-
mated by unconditional Logistic Regression and used to estimate the magni-
tude of the associations between high FPG and adolescent characteristics.
To estimate the ability to identify high FPG in adolescents based on their
family history of diabetes, we aggregated the “Non-classiﬁable” family histories
with the “Negative” family histories. In a clinical setting, the physician has to
classify the family history of diabetes as “positive” or “negative”, and the non-
classiﬁable family histories are usually counted as negative.
Statistical signiﬁcance was accepted at a p value of 0.05. All analyses were
performed using SPSS version 18.0 (SPSS Inc, Chicago, Illinois).Results
From the 2160 participants, 2054 participants performed the physical
examination, but 388 did not agree to a venopuncture, 274 were not
fasting at the time of examination and 6 samples were lost during the
handling procedures. Of the 1386 participants with blood sample, 105
did not hand back their parents questionnaire. Among the 1281 adoles-
centswith complete information,ﬁve participants had a previous diagno-
sis of diabetes. So, we analyzed data from 1276 participants. Comparing
with participants who were not considered in the analyses, those with
complete information presented a higher proportion of girls and adoles-
cents whose parents had a higher economic status (measured by their
higher education and their enrollment to a private school). No signiﬁ-
cant differences were found between those groups in terms of family
history of diabetes in parents or grandparents, categories of BMI or age
at menarche (data not shown).
From the 1276 participants, 332 had fasting plasma glucose above
the 75th percentile (91 mg/dl). Those with higher FPG presented
higher fasting insulin values, were signiﬁcantly more insulin resistant
(HOMA-IR), and had lower insulin sensitivity (QUICKI) (Table 1).
About family history of diabetes, 5 (0.4%) adolescents had both
parents with a diagnosis of diabetes, while in 53 (4.2%) only themother
had diabetes. About grandparental history, 368 adolescents (28.8%) had
just one grandparent with diabetes, 130 (10.2%) had two and only 4
(0.3%) had the four grandparents diagnosed with diabetes.
No signiﬁcant differences were found on mean fasting plasma glu-
cose according to Parental Family History (data not shown). Regarding
Total Family History, mean (standard deviation) of fasting plasma glu-
cose according to the family history status was 86.4 mg/dL (7.2) for
Negative, 85.5 mg/dL (9.0) for Positive and 83.5 mg/dL (11.3) for Non
Classiﬁable. Using the Bonferroni post-hoc test, the difference was sig-
niﬁcant only for: “Negative” vs. “Non classiﬁable”, p b0.001 and “Posi-
tive” vs. “Non classiﬁable”, p = 0.002. No signiﬁcant differences were
found between those classiﬁed as “Negative” versus those classiﬁed as
“Positive” (p = 0.494). No signiﬁcant association was found between
the family history of diabetes, considering only parents information
or the combination of parental and grandparental data, and high FPG
(Table 2).
When we used data only from Parental History, we identiﬁed 103
adolescents with a positive family history of diabetes (8% of partici-
pants). However, combining both parental and grandparental history
(Total Family History), 468 (37% of the total participants) adolescents
were additionally identiﬁed as having a positive history of diabetes
(406 that were initially classiﬁed as negative and 62 that were “non
classiﬁable” based on parents' data). Nevertheless, 276 (28%) of adoles-
cents who were classiﬁed as having a “negative family history” were
re-classiﬁed as “non classiﬁable” when we considered grandparents'
data (Fig. 1).
We calculated the sensitivity, speciﬁcity and positive predictive
value (PPV) of the positive family history of diabetes to identify adoles-
cents with high fasting glucose (Table 3). Considering all adolescents,
when combining grandparental history with parental History's, the
Table 2
Association of individual and familial adolescents' characteristics with a High Fasting Plasma Glucose (FPG ≥ 75th percentile).
Low fasting glucosea
n (%)
High fasting glucosea
n (%)
Crude OR
(95% CI)
Adjusted ORb
(95% CI)
Sex
Female 527 (55.8) 157 (47.3) 0.70 (0.54–0.90) 0.71 (0.55–0.91)
Type of school
Private 245 (26.0) 80 (24.1) 0.91 (0.68–1.21) 1.01 (0.74–1.38)
Parents education
≤ 6 242 (25.9) 78 (24.0) 1 1
7–9 188 (20.2) 90 (27.7) 1.11 (0.77–1.59) 1.46 (1.02–2.08)
10–12 249 (26.7) 83 (25.5) 1.64 (1.15–2.38) 0.99 (0.69–1.41)
≥ 12 254 (27.2) 74 (22.8) 1.14 (0.80–1.64) 0.87 (0.60–1.25)
Missing 11 7
Smoking parents
None 204 (22.0) 63 (19.4) 1 1
One 383 (41.3) 144 (44.3) 0.89 (0.63–1.27) 1.25 (0.89–1.77)
Both 341 (36.7) 118 (36.3) 1.09 (0.82–1.44) 1.15 (0.81–1.65)
Missing 16 7
BMI–Parents
b 24.9 290 (32.2) 98 (31.1) 1 1
25–29.9 437 (48.4) 151 (47.9) 1.02 (0.76–1.37) 0.90 (0.62–1.30)
≥ 30 175 (19.4) 66 (21.0) 1.12 (0.78–1.61) 0.89 (0.63–1.25)
Missing 42 17
Regular practice of sports
No 468 (50.7) 158 (48.3) 1 1
Yes 455 (49.3) 169 (51.7) 0.91 (0.71–1.17) 1.13 (0.86–1.48)
Missing 21 5
Age at menarchec
8–11 176 (39.4) 34 (28.1) 1 1
12 174 (38.9) 60 (49.6) 0.54 (0.33–0.86) 0.52 (0.32–0.84)
≥ 13 or not yet 158 (31.1) 57 (37.8) 0.96 (0.63–1.46) 0.94 (0.61–1.43)
Missing 19 6
Categories of BMI
b 85th percentile 691 (73.4) 232 (69.9) 1 1
85th–95th perc. 158 (16.8) 59 (17.8) 1.11 (0.80–1.55) 1.11 (0.79–1.56)
N 95th percentile 93 (9.9) 41 (12.3) 1.31 (0.88–1.95) 1.30 (0.87–1.94)
Missing 2 0
Parental History
Negative 707 (74.9) 257 (77.4) 1 1
Positive 77 (8.2) 26 (7.8) 0.93 (0.58–1.48) 0.91 (0.57–1.47)
Non classiﬁable 160 (16.9) 49 (14.8) 0.84 (0.59–1.20) 0.76 (0.53–1.11)
Total family history
Negative 214 (22.7) 68 (20.5) 1 1
Positive 412 (43.6) 159 (47.9) 0.96 (0.68–1.37) 1.17 (0.83–1.65)
Nonclassiﬁable 318 (33.7) 105 (31.6) 1.17 (0.88–1.56) 0.95 (0.65–1.37)
a Fasting plasma glucose (FPG) 75th percentile = 91 mg/dl. Low fasting glucose: FPG b 75th percentile. High fasting glucose: FPG ≥ 75th percentile. b OR adjusted for sex and
parents education. c Age at menarche refers only to girls and has a total n = 684.
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decreased from 91.8% to 56.4%. Similar results were found considering
only obese or overweight adolescents. The PPV, this is, the probability
of having high fasting glucose given they have a positive history, is
similar between Parental History and Total Family History.
Discussion
There is an important debate around which should be the cut-point
for the deﬁnition of impaired fasting glucose (IFG). As the prevalence of
IFG and diabetes in our sample was low (4.1%, using ADA criteria (ADA,
2012), we decided to use the FPG's 75th percentile of our sample to
identify those in higher risk to develop IFG or diabetes and its complica-
tions. This option is in conformity with data showing that an elevated
FPG level in childhood, even within the normoglycemic range, is a pre-
dictor of type 2 diabetes in younger adulthood (Nguyen et al., 2010).
This option was also supported by the results showing that those with
a FPG ≥ 75th percentile had a signiﬁcant worse insulin proﬁle regard-
ing data from insulin resistance and sensitivity indexes.
Surprisingly, there was no relationship between adolescents' cate-
gories of BMI and high FPG. However, we found that overweight and
obese adolescents had higher fasting plasma insulin levels and were
more insulin resistant (data not shown). This is consistent with thefact that obesity is considered the major cause of peripheral insulin
resistance in childhood and it is strongly related to the development
of altered glucose metabolism (Cali and Caprio, 2008). Probably, the
absence of association was due to the lack of power, since we have
less than 10% of obese adolescents.Family History and High Fasting Plasma Glucose
No association was found between a positive Family History of
diabetes and a high fasting glucose. This is in disagreement with
Wei et al (Wei et al., 2010), that showed a higher risk for T2DM in ad-
olescents with a family history of diabetes. However, we need to rein-
force that our sample was healthy and population-based and that we
used high fasting glucose as outcome, instead of T2DM.
Other possible explanation could be related with the validity of
the information on parents' and grandparents' data, since most of the
home questionnaires were answered by the mother. However, data
from the Framingham Offspring Study (Murabito et al., 2004) showed
that both positive and negative parental history reports of diabetes
were reliable. Also, Saito et al (Saito et al., 2009), showed that a ques-
tionnaire was a reliable method of collecting students' family history,
including data on grandparents.
282 276
147
406
62
103
0 200 400 600 800 1000
PH Negative (n = 964)
PH Non classifiable (n = 
209)
PH Positive (n = 103)
Maintained as Negative Changed or maintained as Non classifiable Changed or maintained as Positive
Number of adolescents
Fig. 1. Changing in the classiﬁcation of Family History of Diabetes by adding grandparental data to Parental History (PH) alone.
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We found that combining parental with grandparental history of
diabetes lead to a 5.5 fold increase in the identiﬁcation of adolescents
with a positive family history. This could be explained by the fact that
these adolescents' parents are still young (fathers' mean age: 44.8 years
and mothers' mean age: 42.0 years), so most of those that will have a
diagnosis of diabetes, do not have it yet. On the other hand, the use of
grandparental data had the limitation of increasing the amount of ado-
lescents classiﬁed as “Non classiﬁable” due to the missing information.
In this case, they were classiﬁed according to parental history, so that
does not imply lost of informationwhen using total family history, com-
paring with using only parental data.
There was a huge increase in the sensitivity to identify adolescents
with high fasting glucose when we used Total Family History instead
of just Parental History, both in all subjects and in obese/overweight
adolescents. However, speciﬁcity dropped. Nevertheless, as the aim
is to use family history as a screening tool, it is preferable to give way
to a higher sensitivity, since adolescents can be submitted to blood
tests and a tightened follow-up. Additionally, even a false positive may
beneﬁt, as primary interventions have the potential to be protective
for a large set of other diseases (Williams et al., 2001).
Adding grandparental information did not decrease PPV – actually
increased it a little, but not signiﬁcantly. So, combining parental with
parental information may even improve family history's PPV.
Previous studies found that the risk to develop T2DM varied by the
number and type of family members with diabetes (Hemminki et al.,
2010; Meigs et al., 2000; Wei et al., 2010). We would like to test this
issue in our sample, nonetheless among those with high FPG, we only
had 159 adolescents with a positive Total Family History, so there are
not enough cases to perform a strong analysis by number and type of
affected family members.
We decided to exclude those adolescents with a previous diagnosis
of diabetes to test the characteristics of family history to identify ado-
lescents at risk, because the diagnosis of a disease can change the
knowledge on family history, which could falsely improve the perfor-
mance of family history as a screening tool.Table 3
Characteristics of parental and total family history of diabetes to identify adolescents with h
obese adolescentsb – percentage estimates and (95% CI).
Sensiti
All adolescents Parental history 7.8 % (
Total family history 47.9%
Only obese or overweight Parental history 10.0%
Total family history 45.0%
aFasting Plasma Glucose (FPG) 75th percentile = 91 mg/dl. b Adolescents with a Non Cla
analysis. c PPV: Positive Predictive Value.Study limitations
Glucose assays were only run once, not in duplicate: a systematic
review which assessed the reproducibility of IFG in adults showed
that the k coefﬁcients indicated only a moderate agreement for IFG
(0.44 and 0.56) (Balion et al., 2007). An Oral Glucose Tolerance Test
(OGTT) could add some information. However, it would be impossi-
ble to perform an OGTT on such a large sample and reduce the sample
could affect the external validity.
Strengths
A major strength of our study is its relatively large sample size,
which was taken from a nonclinical population. In Portugal, education
ismandatory till 15-year-old, so recruiting 13-year-old adolescents from
school gave us the better sample basis. Besides, we have a good rate of
participation and there were almost no differences between those par-
ticipants not considered in the analyses and those with complete infor-
mation, whichminimizes a possible selection bias. Therefore, we have a
high conﬁdence that our results give a good perspective of our teenage
population.
Family history's assessment wasmade before the clinical evaluation
(including fasting blood sample): the adolescent and his relatives were
not aware of his glycemic statuswhen the questionnaire was answered,
so there is no awareness bias.
Conclusion
We could not ﬁnd an association between a family history of dia-
betes (only parental or combining parental plus grandparental) and a
high fasting glucose. However, combining parental with grandparen-
tal history (Total Family History) leads to a 5.5 fold increase in the
identiﬁcation of adolescents with a positive family history. Also, the
sensitivity to identify adolescents with high fasting glucose increased
from 7.8% to 47.9% using Total Family History. Although its speciﬁcity
is much lower than Parental History's, we know that in a clinical set-
ting, family history is used as a screening tool. So, we can assume thatigh fasting glucose (FPG ≥ 75th percentilea), on all adolescents and on overweight or
vity Speciﬁcity PPVc
5.2–11.3) 91.8% (89.9–93.5) 25.2% (17.2–34.7)
(42.4–53.4) 56.4% (53.1–59.5) 27.8% (24.2–31.7)
(4.9–17.6) 90.5% (86.2–93.8) 29.4% (27.2–31.6)
(35.0–55.3) 51.4% (45.0–57.7) 26.8% (20.2–34.2)
ssiﬁable family history were re-classiﬁed as having a Negative Family History to this
504 M. Brandão et al. / Preventive Medicine 57 (2013) 500–504the use of grandparental information adds relevant information on
adolescent screening for high fasting glucose.
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